INMUNE BIO INC. Earnings Per Share, Basic and Diluted
INMUNE BIO INC. (INMB) reported Earnings Per Share, Basic and Diluted of -$1.88 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-03
- INMUNE BIO INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.54.
- INMUNE BIO INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.55.
- INMUNE BIO INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.44.
- INMUNE BIO INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.32.
- INMUNE BIO INC. earnings per share, basic and diluted for fiscal 2021 was -$1.88.
- INMUNE BIO INC. earnings per share, basic and diluted for fiscal 2020 was -$1.01.
- INMUNE BIO INC. earnings per share, basic and diluted for fiscal 2019 was -$0.75.
- INMUNE BIO INC. earnings per share, basic and diluted for fiscal 2018 was -$1.43.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$1.09 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$1.54 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$1.88 10-K · filed 2022-03-03 |
| 2021-09-30 | -$0.55 10-Q · filed 2021-11-03 | -$1.00 derived: net income ÷ weighted average shares · filed 2022-11-02 | -$1.33 10-Q · filed 2021-11-03 | -$1.59 derived: net income ÷ weighted average shares · filed 2022-11-02 |
| 2021-06-30 | -$0.44 10-Q · filed 2021-08-04 | -$0.77 10-Q · filed 2021-08-04 | -$1.01 derived: net income ÷ weighted average shares · filed 2022-08-03 | -$1.37 derived: net income ÷ weighted average shares · filed 2022-08-03 |
| 2021-03-31 | -$0.32 10-Q · filed 2021-05-05 | -$0.56 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$0.92 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$1.13 derived: net income ÷ weighted average shares · filed 2022-05-05 |
| 2020-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$0.60 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$0.81 derived: net income ÷ weighted average shares · filed 2022-03-03 | -$1.01 10-K · filed 2022-03-03 |
| 2020-09-30 | -$0.36 10-Q · filed 2021-11-03 | -$0.58 derived: net income ÷ weighted average shares · filed 2021-11-03 | -$0.77 10-Q · filed 2021-11-03 | -$0.99 derived: net income ÷ weighted average shares · filed 2021-11-03 |
| 2020-06-30 | -$0.20 10-Q · filed 2021-08-04 | -$0.39 10-Q · filed 2021-08-04 | -$0.60 derived: net income ÷ weighted average shares · filed 2021-08-04 | -$0.89 derived: net income ÷ weighted average shares · filed 2021-08-04 |
| 2020-03-31 | -$0.19 10-Q · filed 2021-05-05 | -$0.41 derived: net income ÷ weighted average shares · filed 2021-05-05 | -$0.69 derived: net income ÷ weighted average shares · filed 2021-05-05 | -$0.74 derived: net income ÷ weighted average shares · filed 2021-05-05 |
| 2019-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$0.50 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$0.55 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$0.75 10-K · filed 2021-03-04 |
| 2019-09-30 | -$0.28 10-Q · filed 2020-11-05 | -$0.33 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$0.53 10-Q · filed 2020-11-05 | -$0.74 derived: net income ÷ weighted average shares · filed 2020-11-05 |
| 2019-06-30 | -$0.04 10-Q · filed 2020-08-05 | -$0.23 10-Q · filed 2020-08-05 | -$0.44 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$0.62 derived: net income ÷ weighted average shares · filed 2020-11-05 |
| 2019-03-31 | -$0.20 10-Q · filed 2020-05-14 | -$0.42 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$0.59 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$1.29 derived: net income ÷ weighted average shares · filed 2020-11-05 |
| 2018-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2020-03-11 | -$0.39 derived: net income ÷ weighted average shares · filed 2020-03-11 | -$1.10 derived: net income ÷ weighted average shares · filed 2020-03-11 | -$1.43 10-K · filed 2020-03-11 |
| 2018-09-30 | -$0.18 10-Q · filed 2019-11-08 | -$0.88 derived: net income ÷ weighted average shares · filed 2019-11-08 | -$1.22 10-Q · filed 2019-11-08 | |
| 2018-06-30 | -$0.71 10-Q · filed 2019-08-09 | -$1.04 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | -$0.33 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | -$0.13 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |